Thus, it is highly desirable to find more potent and selective hCE1 inhibitors for potential biomedical applications, including exploring the functions of hCE1 in biological systems and serving as therapeutic agents for the treatment of obese, type 2 diabetes and hypertriglyceridaemia. Here, CES1 is linked to type 2 diabetes mellitus.